1Probs K,Fijnheer R,Rothova A.Endothelial cell activation and hypercoagulability in ocular Behcet′s disease[J].Am J Ophthalmol,2004,137(5):850-887.
2Sohn S.Etiopathology of Behcet′s disease:herpes simplex virus infet alion and animal model[J].Yonsei Med J,1997,38(6):359-364.
3De Smet MD,Bitar G,Mainigi S,et al.Human S-antigen determinant recognition in uveitis[J].Invest Ophthalmol Vis Sci,2001,42(13):3223-3238.
4Yamada K,Senju S,Nakatsura T,et al.Identification of a novel autoanti-gen UACA in patients with panuveitis[J].Biochem Biophys Res Commun,2001,280(4):1169-1176.
5Mor F,Weinberger A,Cohen IR.Identification of alpha-tropomyosin as a targetself-antigen in Behcet′s syndrome[J].Eur J Immunol,2002,32(2):356-365.
6Menashi S,Tribout B,Dosquet C,et al.Strong association between plasma thrombomodulin and pathergy test in Behcet disease[J].Ann Rheum Dis,2008,67(6):892-893.
7James DG.Silk route disease[J].Postgrad Med J,1986,62(7):151-153.
8Ohno S,Ohguchi M,Hirose S,et al.Close association of HLA-BW51 in Behcet′s disease[J].Arch Ophthalmol,1982,100(9):1455-1458.
9Criteria for diagnosis of Behcet′s disease.Internationl Study Group for Behcet′s disease[J].Lancet,1990,335(869):1078-1080.
10Kotter I,Eckstein A,Stubiger N,et al.Treatment of ocular symptoms of Behcet′s disease with interferon α2a:a pilot study[J].Br J Ophthalmol,1998,82(5):488-494.
